tirzepatide causing anxiety and Anxiety: Mental Health Effects Explained What to Expect on Tirzepatide:
Description
Tirzepatide Tirzepatide is a once-weekly injectable medication originally developed to treat type 2 diabetes

Coming Off Ozempic Cold Turkey: Risks and Safe Discontinuation Stopping Ozempic (semaglutide) abruptlyoften called coming off 'cold turkey'is a decision that requires careful consideration and medical guidance
The effectiveness of dapagliflozin was confirmed by an increase in diuresis

The limitations include the relatively small sample size of the MASLD substudy, the geographic and racial homogeneity of the sample (United States only and majority white), the exclusion of patients with T2D, the absence of liver histology, the lack of enrichment for MASH or significant fibrosis, the lack of multiplicity control given the large number of statistical assessments and the absence of 48-week MRI data for 56.1% of participants, which limits interpretation of the dose-response relationship for liver fat reduction at 48 weeks

See the full FDA Wegovy label for the complete safety profile

Disclosures Chair Lawrence Blonde, MD, FACP, MACE, Endocrinology Department, Ochsner Health, New Orleans, Louisiana consultant: Merck
